Search for Clinical Trial Results

Sponsored By

Neoplasms, Adipose Tissue - 25 Studies Found

Status Study
Recruiting Study Name: Sitagliptin and Brown Adipose Tissue
Condition: Neoplasms, Adipose Tissue
Date: 2014-11-17
Interventions:
  • Drug: Sitagliptin Each subject
Not yet recruiting Study Name: Ultra-sounded Guided Regional Blockade for Lipoma Excision
Condition: Lipomas
Date: 2016-04-24
Interventions: Procedure: Ultrasound guidance In the second arm, ultrasound will be used to guide the regional block
Recruiting Study Name: Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma.
Condition: Lipoma of Spinal Cord
Date: 2016-03-16
Interventions:
  • Procedure: Blood and urine sampling

Completed Study Name: Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
Condition: Lipoma
Date: 2014-08-18
Interventions:
  • Drug: AA4500 Subjects must pre
Completed Study Name: A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Condition: Lipoma
Date: 2012-06-05
Interventions: Drug: Collagenase Clostridium Histolyticum This is a dose escalation study in which subjects will sequen
Completed Study Name: Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
Condition: Lipoma
Date: 2008-02-15
Interventions: Drug: Prednisolone synthetic cortisone and Isoproterenol together Approximately 0.2 to 0.4cc of isoprote
Completed Study Name: Phase 2 Study for the Treatment of Superficial Lipomas
Condition: Lipoma
Date: 2008-01-23
Interventions:
  • Drug: Deoxycholic Acid Injection

Completed Study Name: Deoxycholic Acid Injection for the Treatment of Superficial Lipomas
Condition: Lipoma
Date: 2007-01-11
Interventions:
  • Drug: Deoxycholic Acid Injection

Recruiting Study Name: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Condition:
  • Liposarcomas, Dedifferentiated
  • Liposarcoma - Well Differentiated
  • Liposarcoma
  • Metastatic Liposarcoma

Date: 2016-11-29
Interventions: Drug: MGCD516 Administered at 150 mg orally, daily, in continuous 21 day cycles. An orally available, po
Next >>>